| abstract |
The present invention relates as new industrial products: (a) the peptides corresponding to the formula I: X09 X10 X11 X12 X13 X14 X15 X16 X17 X18 Ser X20 Glu Leu Arg X01 X02 Ser X04 X05 X06 X07 X08 X09 X10 X11 X12 X13 X14 X15 X16 X17 X18 Ser X20 Glu Leu Arg X24 Y25 , X08 , X09 , X10 , X11 , X12 , X13 , X14 , X15 , X16 , X17 , X18 , X20 , X24 and Y25 are defined as indicated in the description, and (b) their non-toxic acid addition salts .These new products are useful in therapy. |